evitria will be attending NextGen Biomed 2026 (24–25 March 2026) at the QEII Centre in London, UK, a leading forum focused on next-generation biologics R&D – from proteins and antibodies (including ADCs) to immunotherapy, vaccines, and emerging modalities.
Our team will be on-site with a booth to discuss how evitria’s flexible recombinant expression services – especially rapid, high-yield CHO-based production for complex and challenging formats – can integrate seamlessly into your discovery and development workflows. Let’s schedule time to connect.